275 related articles for article (PubMed ID: 22729360)
1. 16-kDa prolactin and bromocriptine in postpartum cardiomyopathy.
Hilfiker-Kleiner D; Struman I; Hoch M; Podewski E; Sliwa K
Curr Heart Fail Rep; 2012 Sep; 9(3):174-82. PubMed ID: 22729360
[TBL] [Abstract][Full Text] [Related]
2. Prolactin: a new therapeutic target in peripartum cardiomyopathy.
Yamac H; Bultmann I; Sliwa K; Hilfiker-Kleiner D
Heart; 2010 Sep; 96(17):1352-7. PubMed ID: 20657009
[TBL] [Abstract][Full Text] [Related]
3. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.
Hilfiker-Kleiner D; Kaminski K; Podewski E; Bonda T; Schaefer A; Sliwa K; Forster O; Quint A; Landmesser U; Doerries C; Luchtefeld M; Poli V; Schneider MD; Balligand JL; Desjardins F; Ansari A; Struman I; Nguyen NQ; Zschemisch NH; Klein G; Heusch G; Schulz R; Hilfiker A; Drexler H
Cell; 2007 Feb; 128(3):589-600. PubMed ID: 17289576
[TBL] [Abstract][Full Text] [Related]
4. Peripartum cardiomyopathy: a challenge for cardiologist.
Aursulesei V
Rev Med Chir Soc Med Nat Iasi; 2013; 117(2):358-67. PubMed ID: 24340517
[TBL] [Abstract][Full Text] [Related]
5. [Peripartum cardiomyopathy].
Bretler DM; Jørgensen CH; Olesen JB; Gislason GH; Hansen PR
Ugeskr Laeger; 2009 Jan; 171(1-2):53-5. PubMed ID: 19128569
[TBL] [Abstract][Full Text] [Related]
6. [Peripartum Cardiomyopathy].
Pfeffer TJ; König T; Berliner D; Bauersachs J
Dtsch Med Wochenschr; 2022 Nov; 147(23):1537-1544. PubMed ID: 36384155
[TBL] [Abstract][Full Text] [Related]
7. Peripartum cardiomyopathy: recent insights in its pathophysiology.
Hilfiker-Kleiner D; Sliwa K; Drexler H
Trends Cardiovasc Med; 2008 Jul; 18(5):173-9. PubMed ID: 18790387
[TBL] [Abstract][Full Text] [Related]
8. Peripartum cardiomyopathy--a new treatment option by inhibition of prolactin secretion.
Jahns BG; Stein W; Hilfiker-Kleiner D; Pieske B; Emons G
Am J Obstet Gynecol; 2008 Oct; 199(4):e5-6. PubMed ID: 18928969
[TBL] [Abstract][Full Text] [Related]
9. Circulating microparticles as indicators of peripartum cardiomyopathy.
Walenta K; Schwarz V; Schirmer SH; Kindermann I; Friedrich EB; Solomayer EF; Sliwa K; Labidi S; Hilfiker-Kleiner D; Böhm M
Eur Heart J; 2012 Jun; 33(12):1469-79. PubMed ID: 22307461
[TBL] [Abstract][Full Text] [Related]
10. Molecular events underlying pregnancy-induced cardiomyopathy.
Leinwand LA
Cell; 2007 Feb; 128(3):437-8. PubMed ID: 17289564
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study.
Sliwa K; Blauwet L; Tibazarwa K; Libhaber E; Smedema JP; Becker A; McMurray J; Yamac H; Labidi S; Struman I; Hilfiker-Kleiner D
Circulation; 2010 Apr; 121(13):1465-73. PubMed ID: 20308616
[TBL] [Abstract][Full Text] [Related]
12. Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
Pfeffer TJ; Mueller JH; Haebel L; Erschow S; Yalman KC; Talbot SR; Koenig T; Berliner D; Zwadlo C; Scherr M; Hilfiker-Kleiner D; Bauersachs J; Ricke-Hoch M
ESC Heart Fail; 2023 Feb; 10(1):465-477. PubMed ID: 36300679
[TBL] [Abstract][Full Text] [Related]
13. Recovery from peripartum cardiomyopathy after treatment with bromocriptine.
Habedank D; Kühnle Y; Elgeti T; Dudenhausen JW; Haverkamp W; Dietz R
Eur J Heart Fail; 2008 Nov; 10(11):1149-51. PubMed ID: 18926768
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy.
Haghikia A; Podewski E; Berliner D; Sonnenschein K; Fischer D; Angermann CE; Böhm M; Röntgen P; Bauersachs J; Hilfiker-Kleiner D
Clin Res Cardiol; 2015 Nov; 104(11):911-7. PubMed ID: 26026286
[TBL] [Abstract][Full Text] [Related]
15. Peripartum cardiomyopathy: basic mechanisms and hope for new therapies.
Ricke-Hoch M; Pfeffer TJ; Hilfiker-Kleiner D
Cardiovasc Res; 2020 Mar; 116(3):520-531. PubMed ID: 31605117
[TBL] [Abstract][Full Text] [Related]
16. Pathophysiology and epidemiology of peripartum cardiomyopathy.
Hilfiker-Kleiner D; Sliwa K
Nat Rev Cardiol; 2014 Jun; 11(6):364-70. PubMed ID: 24686946
[TBL] [Abstract][Full Text] [Related]
17. Peripartum cardiomyopathy - a cardiovascular disease in pregnancy and puerperium. The actual state of knowledge, challenges, and perspectives.
Kryczka KE; Demkow M; Dzielinska Z
Ginekol Pol; 2021; 92(2):147-152. PubMed ID: 33084016
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers in Peripartum Cardiomyopathy-What We Know and What Is Still to Be Found.
Kryczka KE; Demkow M; Dzielińska Z
Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254703
[TBL] [Abstract][Full Text] [Related]
19. Peripartum cardiomyopathy.
Koenig T; Hilfiker-Kleiner D; Bauersachs J
Herz; 2018 Aug; 43(5):431-437. PubMed ID: 29767811
[TBL] [Abstract][Full Text] [Related]
20. Prolactin fragmentation by trophoblastic matrix metalloproteinases as a possible contributor to peripartum cardiomyopathy and pre-eclampsia.
Reuwer AQ; Reuwer PJ; van der Post JA; Cramer MJ; Kastelein JJ; Twickler MT
Med Hypotheses; 2010 Feb; 74(2):348-52. PubMed ID: 19748190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
